135 related articles for article (PubMed ID: 34052678)
1. Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound.
Chen S; Bi K; Wu S; Li Y; Huang Y; Sheng C; Dong G
Eur J Med Chem; 2021 Aug; 220():113544. PubMed ID: 34052678
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.
Liang Z; Lei F; Deng J; Zhang H; Wang Y; Li J; Shi T; Yang X; Wang Z
Eur J Med Chem; 2022 Jan; 228():113960. PubMed ID: 34774339
[TBL] [Abstract][Full Text] [Related]
3. Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agents.
Ma Z; Huang Y; Wan K; Zhu F; Sheng C; Chen S; Liu D; Dong G
Bioorg Med Chem Lett; 2021 May; 40():127954. PubMed ID: 33744440
[TBL] [Abstract][Full Text] [Related]
4. Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer.
Wang L; Fang K; Cheng J; Li Y; Huang Y; Chen S; Dong G; Wu S; Sheng C
J Med Chem; 2020 Jan; 63(2):696-713. PubMed ID: 31880942
[TBL] [Abstract][Full Text] [Related]
5. F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent.
Fan S; Cao YX; Li GY; Lei H; Attiogbe MKI; Yao JC; Yang XY; Liu YJ; Hei YY; Zhang H; Cao L; Zhang XY; Du SS; Zhang GM; Zhang SQ
Eur J Med Chem; 2020 Sep; 202():112528. PubMed ID: 32650182
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma.
Fan X; Deng J; Shi T; Wen H; Li J; Liang Z; Lei F; Liu D; Zhang H; Liang Y; Hao X; Wang Z
Bioorg Chem; 2021 Sep; 114():105154. PubMed ID: 34378540
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy.
Liang Z; Wang Y; Zhang H; Deng J; Lei F; Li J; Shi T; Wang S; Li R; Wang Z
Eur J Med Chem; 2022 Sep; 239():114530. PubMed ID: 35728506
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel bis-evodiamine derivatives with potent antitumor activity.
Liang H; Wang W; Zhu F; Chen S; Liu D; Sheng C
Bioorg Med Chem; 2022 Jul; 65():116793. PubMed ID: 35550978
[TBL] [Abstract][Full Text] [Related]
9. 2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents.
Wei XW; Yuan JM; Huang WY; Chen NY; Li XJ; Pan CX; Mo DL; Su GF
Eur J Med Chem; 2020 Jan; 186():111851. PubMed ID: 31761381
[TBL] [Abstract][Full Text] [Related]
10. Novel N-substituted sophoridinol derivatives as anticancer agents.
Bi CW; Zhang CX; Li YH; Tang S; Deng HB; Zhao WL; Wang Z; Shao RG; Song DQ
Eur J Med Chem; 2014 Jun; 81():95-105. PubMed ID: 24826818
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo.
Wang XM; Xin MH; Xu J; Kang BR; Li Y; Lu SM; Zhang SQ
Eur J Med Chem; 2015; 96():382-95. PubMed ID: 25911625
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer.
Zhang L; Fan C; Guo Z; Li Y; Zhao S; Yang S; Yang Y; Zhu J; Lin D
Eur J Med Chem; 2013 Nov; 69():833-41. PubMed ID: 24121234
[TBL] [Abstract][Full Text] [Related]
13. Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.
Wang S; Fang K; Dong G; Chen S; Liu N; Miao Z; Yao J; Li J; Zhang W; Sheng C
J Med Chem; 2015 Aug; 58(16):6678-96. PubMed ID: 26226379
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents.
Liu Y; Wu Y; Sun L; Gu Y; Hu L
Eur J Med Chem; 2020 Apr; 191():112181. PubMed ID: 32113125
[TBL] [Abstract][Full Text] [Related]
15. Alkylsulfonamide-containing quinazoline derivatives as potent and orally bioavailable PI3Ks inhibitors.
Hei YY; Zhang SQ; Feng Y; Wang J; Duan W; Zhang H; Mao S; Sun H; Xin M
Bioorg Med Chem; 2019 Oct; 27(20):114930. PubMed ID: 31176568
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity study of quinazoline derivatives leading to the discovery of potent EGFR-T790M inhibitors.
Zhang L; Yang Y; Zhou H; Zheng Q; Li Y; Zheng S; Zhao S; Chen D; Fan C
Eur J Med Chem; 2015 Sep; 102():445-63. PubMed ID: 26310890
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo.
Pang Y; Lin H; Ou C; Cao Y; An B; Yan J; Li X
Eur J Med Chem; 2019 Nov; 182():111670. PubMed ID: 31499359
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.
Shen QK; Deng H; Wang SB; Tian YS; Quan ZS
Eur J Med Chem; 2019 Jul; 173():15-31. PubMed ID: 30981113
[TBL] [Abstract][Full Text] [Related]
19. Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers.
Zhou Y; Li X; Chen K; Ba Q; Zhang X; Li J; Wang J; Wang H; Liu H
Eur J Med Chem; 2021 Feb; 211():113000. PubMed ID: 33261896
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]